235 related articles for article (PubMed ID: 6119322)
1. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
2. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Hashimoto's thyroiditis (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1275-85. PubMed ID: 228999
[TBL] [Abstract][Full Text] [Related]
4. Placental transmission of thyroid-stimulating immunoglobulins.
Dirmikis SM; Munro DS
Br Med J; 1975 Jun; 2(5972):665-6. PubMed ID: 1173561
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyroidism in an infant of a mother with autoimmune hypothyroidism with positive TSH receptor antibodies.
Joshi K; Zacharin M
J Pediatr Endocrinol Metab; 2018 Apr; 31(5):577-580. PubMed ID: 29494342
[TBL] [Abstract][Full Text] [Related]
6. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.
von Westarp C; Knox AJ; Row VV; Volpé R
Acta Endocrinol (Copenh); 1977 Apr; 84(4):759-67. PubMed ID: 576759
[TBL] [Abstract][Full Text] [Related]
7. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
8. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy induces the presence of a thyroid-stimulating antibody in a thyrotropin-binding inhibitory immunoglobulin positive, hypothyroid woman with transient thyrotoxicosis in offspring.
Chang TC; Lee JS
J Formos Med Assoc; 1990 Aug; 89(8):709-13. PubMed ID: 1981235
[TBL] [Abstract][Full Text] [Related]
10. Transient neonatal hyperthyroidism and maternal thyroid stimulating immunoglobulins.
Matsuda T; Momoi T; Akaishi K; Yagura T; Kasagi K; Endo K
Arch Dis Child; 1988 Feb; 63(2):205-7. PubMed ID: 2894819
[TBL] [Abstract][Full Text] [Related]
11. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
12. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
Selenkow HA; Wyman P; Allweiss P
Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
[TBL] [Abstract][Full Text] [Related]
15. Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).
Mitchell I; Shenfield G; Brash J
Arch Dis Child; 1976 Jul; 51(7):565-7. PubMed ID: 962368
[TBL] [Abstract][Full Text] [Related]
16. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
17. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune thyroid disease.
Bottazzo GF; Doniach D
Annu Rev Med; 1986; 37():353-9. PubMed ID: 2871804
[TBL] [Abstract][Full Text] [Related]
19. Neonatal thyroid disease: differential expression in three successive offspring.
Fort P; Lifshitz F; Pugliese M; Klein I
J Clin Endocrinol Metab; 1988 Mar; 66(3):645-7. PubMed ID: 2895120
[TBL] [Abstract][Full Text] [Related]
20. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
Chopra IJ; Solomon DH; Limberg NP
J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
[No Abstract] [Full Text] [Related]
[Next] [New Search]